| 1 | Macs syndrome | Enrichment | PAX6, SHH, SIX6, SOX2 | 4.32 |
| 2 | Microphthalmia | Enrichment | PAX6, SIX6, SOX2, TFAP2A | 4.15 |
| 3 | Ectodermal dysplasia 1, hypohidrotic, x-linked | Enrichment | EDA, EDA2R | 3.97 |
| 4 | Cat eye syndrome | Enrichment | FZD5, PAX6, TFAP2A | 3.90 |
| 5 | Septooptic dysplasia | Enrichment | HESX1, SHH, SOX2 | 3.65 |
| 6 | Microphthalmia/coloboma 12 | Enrichment | CDON, FZD5, PAX6 | 3.54 |
| 7 | Acute promyelocytic leukemia | Enrichment | BCOR, NUMA1, ZBTB16 | 3.54 |
| 8 | Juvenile polyposis syndrome | Enrichment | BMPR1A, SMAD4 | 3.50 |
| 9 | Coloboma of macula | Enrichment | CDON, FZD5, PAX6 | 3.34 |
| 10 | Eyelid coloboma | Enrichment | FZD5, PAX6 | 3.20 |
| 11 | Lens coloboma | Enrichment | FZD5, PAX6 | 3.20 |
| 12 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1, FZD4 | 2.98 |
| 13 | Congenital heart defects, multiple types, 4 | Enrichment | GATA6, NR2F2 | 2.98 |
| 14 | Joubert syndrome with ocular defect | Enrichment | AHI1, MKS1 | 2.98 |
| 15 | Coloboma of choroid and retina | Enrichment | FZD5, PAX6 | 2.98 |
| 16 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | BMPR1A, SMAD4 | 2.98 |
| 17 | Coloboma of optic nerve | Enrichment | FZD5, PAX6 | 2.81 |
| 18 | Anterior segment dysgenesis 5 | Enrichment | BMP4, PAX6 | 2.81 |
| 19 | Hypertelorism | Enrichment | FGFR2, PAX6, RIT1, TFAP2A | 2.69 |
| 20 | Gallbladder cancer | Enrichment | CTNNB1, SMAD4 | 2.66 |
| 21 | Spastic ataxia | Enrichment | CCDC88C, ELOVL4, GLB1, MKS1 | 2.66 |
| 22 | Exudative vitreoretinopathy | Enrichment | CTNNB1, FZD4 | 2.54 |
| 23 | Combined pituitary hormone deficiency | Enrichment | FOXA2, HESX1 | 2.54 |
| 24 | Tooth agenesis, selective, 1 | Enrichment | EDA, EDA2R | 2.43 |
| 25 | Peters-plus syndrome | Enrichment | BMP4, PAX6 | 2.34 |
| 26 | Meningioma, familial | Enrichment | NF2, SCHIP1 | 2.26 |
| 27 | Nanophthalmos | Enrichment | SIX6, SOX2 | 2.26 |
| 28 | Non-syndromic x-linked intellectual disability | Enrichment | ARX, DMD, MECP2 | 2.21 |
| 29 | Early-onset parkinson's disease | Enrichment | PODXL, SNCA | 2.18 |
| 30 | Diaphragmatic hernia, congenital | Enrichment | GATA6, GLI3 | 2.11 |
| 31 | Heart disease | Enrichment | NR2F2, RIT1 | 2.05 |
| 32 | Pituitary stalk interruption syndrome | Enrichment | CDON, HESX1 | 2.05 |
| 33 | Hydrocephalus | Enrichment | CCDC88C, FGFR2 | 1.99 |
| 34 | Septopreoptic holoprosencephaly | Enrichment | CDON, SHH | 1.99 |
| 35 | Midline interhemispheric variant of holoprosencephaly | Enrichment | CDON, SHH | 1.99 |
| 36 | Holoprosencephaly 3 | Enrichment | SHH | 1.98 |
| 37 | Pallister-hall syndrome | Enrichment | GLI3 | 1.98 |
| 38 | Brachydactyly, type b1 | Enrichment | ROR2 | 1.98 |
| 39 | Multicentric carpotarsal osteolysis syndrome | Enrichment | MAFB | 1.98 |
| 40 | Craniofacial-deafness-hand syndrome | Enrichment | PAX3 | 1.98 |
| 41 | Beare-stevenson cutis gyrata syndrome | Enrichment | FGFR2 | 1.98 |
| 42 | Greig cephalopolysyndactyly syndrome | Enrichment | GLI3 | 1.98 |
| 43 | Waardenburg syndrome, type 3 | Enrichment | PAX3 | 1.98 |
| 44 | Parkinson disease 1, autosomal dominant | Enrichment | SNCA | 1.98 |
| 45 | Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia | Enrichment | HDAC6 | 1.98 |
| 46 | Intellectual developmental disorder, x-linked, syndromic, siderius type | Enrichment | PHF8 | 1.98 |
| 47 | Hypothyroidism, congenital, nongoitrous, 8 | Enrichment | TBL1X | 1.98 |
| 48 | Developmental and epileptic encephalopathy 8 | Enrichment | ARHGEF9 | 1.98 |
| 49 | Arrhythmogenic right ventricular dysplasia, familial, 12 | Enrichment | JUP | 1.98 |
| 50 | Muscular dystrophy, becker type | Enrichment | DMD | 1.98 |
| 51 | Facial hypertrichosis | Enrichment | MECP2 | 1.98 |
| 52 | Joubert syndrome 3 | Enrichment | AHI1 | 1.98 |
| 53 | Polydactyly, preaxial iv | Enrichment | GLI3 | 1.98 |
| 54 | Scaphocephaly, maxillary retrusion, and impaired intellectual development | Enrichment | FGFR2 | 1.98 |
| 55 | Polyposis syndrome, hereditary mixed, 2 | Enrichment | BMPR1A | 1.98 |
| 56 | Schwannomatosis, vestibular | Enrichment | NF2 | 1.98 |
| 57 | Apert syndrome | Enrichment | FGFR2 | 1.98 |
| 58 | Skeletal defects, genital hypoplasia, and impaired intellectual development | Enrichment | ZBTB16 | 1.98 |
| 59 | Microphthalmia/coloboma 5 | Enrichment | SHH | 1.98 |
| 60 | Spinocerebellar ataxia 34 | Enrichment | ELOVL4 | 1.98 |
| 61 | Parkinson disease 4, autosomal dominant | Enrichment | SNCA | 1.98 |
| 62 | Iga nephropathy 3 | Enrichment | SPRY2 | 1.98 |
| 63 | Pachyonychia congenita 3 | Enrichment | KRT6A | 1.98 |
| 64 | Atrioventricular septal defect 5 | Enrichment | GATA6 | 1.98 |
| 65 | Bent bone dysplasia syndrome 1 | Enrichment | FGFR2 | 1.98 |
| 66 | Naxos disease | Enrichment | JUP | 1.98 |
| 67 | Intellectual developmental disorder, x-linked, syndromic, lubs type | Enrichment | MECP2 | 1.98 |
| 68 | Cardiomyopathy, dilated, 2i | Enrichment | CAP2 | 1.98 |
| 69 | Agammaglobulinemia 8b, autosomal recessive | Enrichment | TCF3 | 1.98 |
| 70 | Autism x-linked 3 | Enrichment | MECP2 | 1.98 |
| 71 | Cortical dysplasia, complex, with other brain malformations 9 | Enrichment | CTNNA2 | 1.98 |
| 72 | 46,xx sex reversal 5 | Enrichment | NR2F2 | 1.98 |
| 73 | Cardiomyopathy, dilated, 3b | Enrichment | DMD | 1.98 |
| 74 | Microphthalmia, syndromic 6 | Enrichment | BMP4 | 1.98 |
| 75 | Syndromic x-linked intellectual disability siderius type | Enrichment | PHF8 | 1.98 |
| 76 | Intellectual developmental disorder, x-linked 106 | Enrichment | OGT | 1.98 |
| 77 | Orofacial cleft 11 | Enrichment | BMP4 | 1.98 |
| 78 | Cardiomyopathy, familial hypertrophic, 6 | Enrichment | PRKAG2 | 1.98 |
| 79 | Tooth agenesis, selective, x-linked, 1 | Enrichment | EDA | 1.98 |
| 80 | Glycogen storage disease of heart, lethal congenital | Enrichment | PRKAG2 | 1.98 |
| 81 | Bone mineral density quantitative trait locus 16 | Enrichment | WNT1 | 1.98 |
| 82 | Agammaglobulinemia 8a, autosomal dominant | Enrichment | TCF3 | 1.98 |
| 83 | Spinocerebellar ataxia 40 | Enrichment | CCDC88C | 1.98 |
| 84 | Ichthyosis, spastic quadriplegia, and impaired intellectual development | Enrichment | ELOVL4 | 1.98 |
| 85 | Holoprosencephaly 11 | Enrichment | CDON | 1.98 |
| 86 | Deafness, autosomal recessive 91 | Enrichment | SERPINB6 | 1.98 |
| 87 | Otosclerosis 11 | Enrichment | FOXL1 | 1.98 |
| 88 | Syndromic x-linked intellectual disability lubs type | Enrichment | MECP2 | 1.98 |
| 89 | Microphthalmia/coloboma 11 | Enrichment | FZD5 | 1.98 |
| 90 | Atrial septal defect 9 | Enrichment | GATA6 | 1.98 |
| 91 | Leukodystrophy, hypomyelinating, 22 | Enrichment | CLDN11 | 1.98 |
| 92 | Duane retraction syndrome 3 with or without deafness | Enrichment | MAFB | 1.98 |
| 93 | Basal ganglia calcification, idiopathic, 7, autosomal recessive | Enrichment | MYORG | 1.98 |
| 94 | Deafness, autosomal recessive 94 | Enrichment | NARS2 | 1.98 |
| 95 | Autism 20 | Enrichment | NLGN1 | 1.98 |
| 96 | Spastic paraplegia 84, autosomal recessive | Enrichment | PI4KA | 1.98 |
| 97 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.98 |
| 98 | Heritable thoracic aortic disease | Enrichment | SMAD4 | 1.98 |
| 99 | Non-acquired combined pituitary hormone deficiency | Enrichment | FOXA2 | 1.98 |
| 100 | Developmental dysplasia of the hip 4 | Enrichment | TRIM33 | 1.98 |
| 101 | Symptomatic form of muscular dystrophy of duchenne and becker in female carriers | Enrichment | DMD | 1.98 |
| 102 | X-linked spasticity-intellectual disability-epilepsy syndrome | Enrichment | ARX | 1.98 |
| 103 | Duane retraction syndrome 3 | Enrichment | MAFB | 1.98 |
| 104 | Acoustic neuroma | Enrichment | NF2 | 1.98 |
| 105 | Glb1-related disorders | Enrichment | GLB1 | 1.98 |
| 106 | Duchenne and becker muscular dystrophy | Enrichment | DMD | 1.98 |
| 107 | Duane retraction syndrome with congenital deafness | Enrichment | MAFB | 1.98 |
| 108 | Gastrointestinal defects and immunodeficiency syndrome 2 | Enrichment | PI4KA | 1.98 |
| 109 | Dislocation of the hip-dysmorphism syndrome | Enrichment | TRIM33 | 1.98 |
| 110 | Non-syndromic unicoronal craniosynostosis | Enrichment | FGFR2 | 1.98 |
| 111 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.98 |
| 112 | Qualitative or quantitative defects of dystrophin | Enrichment | DMD | 1.98 |
| 113 | Pi4ka-related disorder | Enrichment | PI4KA | 1.98 |
| 114 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 1.98 |
| 115 | Wolff-parkinson-white syndrome | Enrichment | JUP, PRKAG2 | 1.93 |
| 116 | Hydrocephalus, congenital, 1 | Enrichment | ARX, CCDC88C | 1.93 |
| 117 | Microform holoprosencephaly | Enrichment | CDON, SHH | 1.93 |
| 118 | Lobar holoprosencephaly | Enrichment | CDON, SHH | 1.93 |
| 119 | Colorectal cancer | Enrichment | CTNNB1, DMD, FGFR2, SMAD4 | 1.89 |
| 120 | Alobar holoprosencephaly | Enrichment | CDON, SHH | 1.88 |
| 121 | Semilobar holoprosencephaly | Enrichment | CDON, SHH | 1.83 |
| 122 | Familial isolated dilated cardiomyopathy | Enrichment | CAP2, DMD, FHL2 | 1.75 |
| 123 | Craniosynostosis | Enrichment | FGFR2, GLI3 | 1.74 |
| 124 | Cri-du-chat syndrome | Enrichment | CTNND2 | 1.68 |
| 125 | Keratitis, hereditary | Enrichment | PAX6 | 1.68 |
| 126 | Burkitt lymphoma | Enrichment | MYC | 1.68 |
| 127 | Foveal hypoplasia 1 | Enrichment | PAX6 | 1.68 |
| 128 | Myhre syndrome | Enrichment | SMAD4 | 1.68 |
| 129 | Duane retraction syndrome 1 | Enrichment | MAFB | 1.68 |
| 130 | Paget disease of bone 5, juvenile-onset | Enrichment | TNFRSF11B | 1.68 |
| 131 | Microphthalmia, syndromic 1 | Enrichment | BCOR | 1.68 |
| 132 | Optic disc anomalies with retinal and/or macular dystrophy | Enrichment | SIX6 | 1.68 |
| 133 | Corpus callosum, agenesis of, with abnormal genitalia | Enrichment | ARX | 1.68 |
| 134 | Lissencephaly, x-linked, 2 | Enrichment | ARX | 1.68 |
| 135 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.68 |
| 136 | Intellectual developmental disorder, x-linked 29 | Enrichment | ARX | 1.68 |
| 137 | Encephalopathy, neonatal severe, due to mecp2 mutations | Enrichment | MECP2 | 1.68 |
| 138 | Microphthalmia, syndromic 2 | Enrichment | BCOR | 1.68 |
| 139 | Aicardi syndrome | Enrichment | ARX | 1.68 |
| 140 | Stargardt disease 3 | Enrichment | ELOVL4 | 1.68 |
| 141 | Schwannomatosis 1 | Enrichment | NF2 | 1.68 |
| 142 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | Enrichment | SMAD4 | 1.68 |
| 143 | Alzheimer disease 6 | Enrichment | SORCS1 | 1.68 |
| 144 | Aural atresia, congenital | Enrichment | FGFR2 | 1.68 |
| 145 | Pfeiffer syndrome | Enrichment | FGFR2 | 1.68 |
| 146 | Osteogenesis imperfecta, type xv | Enrichment | WNT1 | 1.68 |
| 147 | Jackson-weiss syndrome | Enrichment | FGFR2 | 1.68 |
| 148 | Pituitary hormone deficiency, combined or isolated, 1 | Enrichment | HESX1 | 1.68 |
| 149 | Solitary median maxillary central incisor | Enrichment | SHH | 1.68 |
| 150 | Optic nerve hypoplasia, bilateral | Enrichment | PAX6 | 1.68 |
| 151 | Duane retraction syndrome 2 | Enrichment | MAFB | 1.68 |
| 152 | Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities | Enrichment | PI4KA | 1.68 |
| 153 | Congenital disorder of glycosylation, type it | Enrichment | PGM1 | 1.68 |
| 154 | Noonan syndrome 8 | Enrichment | RIT1 | 1.68 |
| 155 | Leber congenital amaurosis 6 | Enrichment | MKS1 | 1.68 |
| 156 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis | Enrichment | FGFR2 | 1.68 |
| 157 | Neutropenia, severe congenital, 8, autosomal dominant | Enrichment | GATA6 | 1.68 |
| 158 | Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome | Enrichment | CTBP1 | 1.68 |
| 159 | Ciliary dyskinesia, primary, 14 | Enrichment | TTC14 | 1.68 |
| 160 | Intellectual developmental disorder, x-linked, syndromic 13 | Enrichment | MECP2 | 1.68 |
| 161 | Parkinson disease 15, autosomal recessive early-onset | Enrichment | SNCA | 1.68 |
| 162 | Tibial hemimelia | Enrichment | GLI3 | 1.68 |
| 163 | Cornea plana | Enrichment | SIX6 | 1.68 |
| 164 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.68 |
| 165 | Split hand-foot malformation | Enrichment | FGFR2 | 1.68 |
| 166 | Synpolydactyly | Enrichment | GLI3 | 1.68 |
| 167 | X-linked intellectual disability-psychosis-macroorchidism syndrome | Enrichment | MECP2 | 1.68 |
| 168 | Bardet-biedl syndrome 13 | Enrichment | MKS1 | 1.68 |
| 169 | Joubert syndrome 28 | Enrichment | MKS1 | 1.68 |
| 170 | Esotropia | Enrichment | TFAP2A | 1.68 |
| 171 | Hereditary mixed polyposis syndrome | Enrichment | BMPR1A | 1.68 |
| 172 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.68 |
| 173 | Combined immunodeficiency-multiple intestinal atresia | Enrichment | PI4KA | 1.68 |
| 174 | Hengel-maroofian-schols syndrome | Enrichment | BCAS3 | 1.68 |
| 175 | Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome | Enrichment | SIX6 | 1.68 |
| 176 | B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3) | Enrichment | TCF3 | 1.68 |
| 177 | Postaxial polydactyly type b | Enrichment | GLI3 | 1.68 |
| 178 | Autosomal dominant nonsyndromic deafness | Enrichment | FGFR2 | 1.68 |
| 179 | Teratoma | Enrichment | CTNNB1 | 1.68 |
| 180 | B-lymphoblastic leukemia/lymphoma with t(17;19) | Enrichment | TCF3 | 1.68 |
| 181 | Juvenile polyposis of infancy | Enrichment | BMPR1A | 1.68 |
| 182 | Isolated radial hemimelia | Enrichment | SHH | 1.68 |
| 183 | Lens subluxation | Enrichment | TFAP2A | 1.68 |
| 184 | Progressive bulbar palsy | Enrichment | MECP2 | 1.68 |
| 185 | Bruxism | Enrichment | MECP2 | 1.68 |
| 186 | Tooth agenesis | Enrichment | EDA, EDA2R | 1.66 |
| 187 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | MYC, ZBTB16 | 1.63 |
| 188 | Crouzon syndrome | Enrichment | FGFR2 | 1.51 |
| 189 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.51 |
| 190 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGFR2 | 1.51 |
| 191 | Laryngomalacia | Enrichment | MECP2 | 1.51 |
| 192 | Gm1-gangliosidosis, type i | Enrichment | GLB1 | 1.51 |
| 193 | Mucopolysaccharidosis, type ivb | Enrichment | GLB1 | 1.51 |
| 194 | Acrocallosal syndrome | Enrichment | GLI3 | 1.51 |
| 195 | Gillespie syndrome | Enrichment | PAX6 | 1.51 |
| 196 | Gm1-gangliosidosis, type ii | Enrichment | GLB1 | 1.51 |
| 197 | Syndactyly, type iv | Enrichment | SHH | 1.51 |
| 198 | Aarskog-scott syndrome | Enrichment | GLI3 | 1.51 |
| 199 | Partington syndrome | Enrichment | ARX | 1.51 |
| 200 | Heart defects, congenital, and other congenital anomalies | Enrichment | GATA6 | 1.51 |
| 201 | Tooth agenesis, selective, 2 | Enrichment | EDA | 1.51 |
| 202 | Muscular dystrophy, duchenne type | Enrichment | DMD | 1.51 |
| 203 | Osteoporosis, juvenile | Enrichment | WNT1 | 1.51 |
| 204 | Heparin cofactor ii deficiency | Enrichment | PI4KA | 1.51 |
| 205 | Epidermolysis bullosa, lethal acantholytic | Enrichment | JUP | 1.51 |
| 206 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.51 |
| 207 | Combined oxidative phosphorylation deficiency 1 | Enrichment | NARS2 | 1.51 |
| 208 | Gm1-gangliosidosis, type iii | Enrichment | GLB1 | 1.51 |
| 209 | Chromosome 17q12 deletion syndrome | Enrichment | LHX1 | 1.51 |
| 210 | Anus, imperforate | Enrichment | CTNNB1 | 1.51 |
| 211 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.51 |
| 212 | Umbilical hernia | Enrichment | GLI3 | 1.51 |
| 213 | Desmoid tumor | Enrichment | CTNNB1 | 1.51 |
| 214 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | MYC | 1.51 |
| 215 | Gm1 gangliosidosis | Enrichment | GLB1 | 1.51 |
| 216 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 1.51 |
| 217 | Cellular ependymoma | Enrichment | NF2 | 1.51 |
| 218 | Tanycytic ependymoma | Enrichment | NF2 | 1.51 |
| 219 | Papillary ependymoma | Enrichment | NF2 | 1.51 |
| 220 | Duane retraction syndrome | Enrichment | MAFB | 1.51 |
| 221 | Neurodegeneration, childhood-onset, with brain atrophy | Enrichment | UBTF | 1.51 |
| 222 | Arachnoid cyst | Enrichment | ARX | 1.51 |
| 223 | Atypical juvenile parkinsonism | Enrichment | PODXL | 1.51 |
| 224 | Sclerocornea | Enrichment | SIX6 | 1.51 |
| 225 | Spindle cell sarcoma | Enrichment | NF2 | 1.51 |
| 226 | Clear cell ependymoma | Enrichment | NF2 | 1.51 |
| 227 | Dend syndrome | Enrichment | NARS2 | 1.51 |
| 228 | Congenital cornea plana | Enrichment | SIX6 | 1.51 |
| 229 | Isolated joubert syndrome | Enrichment | AHI1, MKS1 | 1.41 |
| 230 | Autism | Enrichment | DMD, MECP2, SHH | 1.41 |
| 231 | Aniridia 1 | Enrichment | PAX6 | 1.39 |
| 232 | Branchiooculofacial syndrome | Enrichment | TFAP2A | 1.39 |
| 233 | Polydactyly, preaxial ii | Enrichment | SHH | 1.39 |
| 234 | Pachyonychia congenita 1 | Enrichment | KRT6A | 1.39 |
| 235 | Ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive | Enrichment | EDA | 1.39 |
| 236 | Microphthalmia, syndromic 3 | Enrichment | SOX2 | 1.39 |
| 237 | Schizencephaly | Enrichment | SHH | 1.39 |
| 238 | Pseudohypoparathyroidism, type ib | Enrichment | STX16 | 1.39 |
| 239 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | RIT1 | 1.39 |
| 240 | Orofaciodigital syndrome iii | Enrichment | CELSR2 | 1.39 |
| 241 | Saethre-chotzen syndrome | Enrichment | FGFR2 | 1.39 |
| 242 | Pilomatrixoma | Enrichment | CTNNB1 | 1.39 |
| 243 | Chondrocalcinosis 2 | Enrichment | TNFRSF11B | 1.39 |
| 244 | Alazami syndrome | Enrichment | CTNNB1 | 1.39 |
| 245 | Basal ganglia calcification | Enrichment | MYORG | 1.39 |
| 246 | Ectodermal dysplasia | Enrichment | EDA | 1.39 |
| 247 | Retinopathy of prematurity | Enrichment | FZD4 | 1.39 |
| 248 | Combined oxidative phosphorylation deficiency 24 | Enrichment | NARS2 | 1.39 |
| 249 | Craniopharyngioma | Enrichment | CTNNB1 | 1.39 |
| 250 | Sick sinus syndrome | Enrichment | MECP2 | 1.39 |
| 251 | Full schwannomatosis | Enrichment | NF2 | 1.39 |
| 252 | Glioma | Enrichment | FGFR2 | 1.39 |
| 253 | Benign ependymoma | Enrichment | NF2 | 1.39 |
| 254 | Middle aortic syndrome | Enrichment | GATA6 | 1.39 |
| 255 | Familial hypertrophic cardiomyopathy | Enrichment | DMD, PRKAG2 | 1.34 |
| 256 | Dilated cardiomyopathy | Enrichment | DMD, GATA6, JUP | 1.30 |
| 257 | Hemifacial hyperplasia | Enrichment | FGFR2 | 1.29 |
| 258 | Dementia, lewy body | Enrichment | SNCA | 1.29 |
| 259 | Robinow syndrome, autosomal recessive 1 | Enrichment | ROR2 | 1.29 |
| 260 | Parkinson disease 2, autosomal recessive juvenile | Enrichment | PODXL | 1.29 |
| 261 | Norrie disease | Enrichment | FZD4 | 1.29 |
| 262 | Rhabdomyosarcoma 2 | Enrichment | PAX3 | 1.29 |
| 263 | Amblyopia | Enrichment | TFAP2A | 1.29 |
| 264 | Congenital ptosis | Enrichment | ZFHX4 | 1.29 |
| 265 | Persistent hyperplastic primary vitreous | Enrichment | FZD4 | 1.29 |
| 266 | Parkin type of early-onset parkinson disease | Enrichment | PODXL | 1.29 |
| 267 | Aniridia | Enrichment | PAX6 | 1.29 |
| 268 | Rare syndromic intellectual disability | Enrichment | UBTF | 1.29 |
| 269 | Persistent truncus arteriosus | Enrichment | GATA6 | 1.29 |
| 270 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | Enrichment | HESX1 | 1.29 |
| 271 | Angelman syndrome | Enrichment | MECP2 | 1.22 |
| 272 | Spondyloepiphyseal dysplasia with congenital joint dislocations | Enrichment | GLB1 | 1.22 |
| 273 | Developmental dysplasia of the hip 1 | Enrichment | TRIM33 | 1.22 |
| 274 | Branchiootorenal syndrome 1 | Enrichment | TFAP2A | 1.22 |
| 275 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.22 |
| 276 | Wolf-hirschhorn syndrome | Enrichment | CTBP1 | 1.22 |
| 277 | Conotruncal heart malformations | Enrichment | GATA6 | 1.22 |
| 278 | Split-hand/foot malformation 1 | Enrichment | FGFR2 | 1.22 |
| 279 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | PAX6 | 1.22 |
| 280 | Familial adult myoclonic epilepsy | Enrichment | CTNND2 | 1.22 |
| 281 | Autosomal recessive robinow syndrome | Enrichment | ROR2 | 1.22 |
| 282 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.22 |
| 283 | Waardenburg syndrome | Enrichment | PAX3 | 1.22 |
| 284 | 46,xy disorder of sex development | Enrichment | NR2F2 | 1.22 |
| 285 | Kidney clear cell sarcoma | Enrichment | BCOR | 1.22 |
| 286 | Waardenburg syndrome, type 1 | Enrichment | PAX3 | 1.15 |
| 287 | Rett syndrome | Enrichment | MECP2 | 1.15 |
| 288 | Coats disease | Enrichment | FZD4 | 1.15 |
| 289 | Progressive familial intrahepatic cholestasis | Enrichment | GLB1 | 1.15 |
| 290 | Branchiootorenal syndrome | Enrichment | TFAP2A | 1.15 |
| 291 | Hereditary hemorrhagic telangiectasia | Enrichment | SMAD4 | 1.15 |
| 292 | Focal epilepsy | Enrichment | MECP2 | 1.15 |
| 293 | Congenital hydrocephalus | Enrichment | CCDC88C | 1.15 |
| 294 | Gastric cancer | Enrichment | FGFR2, SMAD4 | 1.13 |
| 295 | Basal ganglia calcification, idiopathic, 1 | Enrichment | MYORG | 1.10 |
| 296 | Rett syndrome, congenital variant | Enrichment | MECP2 | 1.10 |
| 297 | Orofacial cleft 1 | Enrichment | MAFB | 1.05 |
| 298 | Tracheoesophageal fistula with or without esophageal atresia | Enrichment | CELSR2 | 1.05 |
| 299 | Polydactyly | Enrichment | MKS1 | 1.05 |
| 300 | Adult hepatocellular carcinoma | Enrichment | CTNNB1 | 1.05 |
| 301 | Bilateral perisylvian polymicrogyria | Enrichment | PI4KA | 1.05 |
| 302 | Joubert syndrome 1 | Enrichment | AHI1, MKS1 | 1.02 |
| 303 | Meier-gorlin syndrome 1 | Enrichment | FGFR2 | 1.00 |
| 304 | Stickler syndrome | Enrichment | BMP4 | 1.00 |
| 305 | Isolated tracheo-esophageal fistula | Enrichment | CELSR2 | 1.00 |
| 306 | Autosomal non-syndromic agammaglobulinemia | Enrichment | TCF3 | 1.00 |
| 307 | Pectus excavatum | Enrichment | DMD | 0.96 |
| 308 | Atrial heart septal defect | Enrichment | DMD | 0.96 |
| 309 | Interatrial communication | Enrichment | DMD | 0.96 |
| 310 | Familial colorectal cancer type x | Enrichment | BMPR1A | 0.96 |
| 311 | Epicanthus | Enrichment | TFAP2A | 0.93 |
| 312 | Renal hypodysplasia/aplasia 3 | Enrichment | BMP4 | 0.93 |
| 313 | Meningioma | Enrichment | NF2 | 0.93 |
| 314 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | JUP | 0.93 |
| 315 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | JUP | 0.93 |
| 316 | Schizophrenia | Enrichment | CTNND2, DMD | 0.90 |
| 317 | Osteogenesis imperfecta, type iv | Enrichment | WNT1 | 0.90 |
| 318 | Stereotypic movement disorder | Enrichment | MECP2 | 0.90 |
| 319 | Chronic kidney disease | Enrichment | MKS1 | 0.90 |
| 320 | Osteoporosis | Enrichment | WNT1 | 0.87 |
| 321 | Medulloblastoma | Enrichment | CTNNB1 | 0.87 |
| 322 | Periventricular nodular heterotopia | Enrichment | ARX | 0.87 |
| 323 | Cleft lip/palate | Enrichment | BMP4 | 0.87 |
| 324 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | JUP | 0.87 |
| 325 | Polydactyly, postaxial, type a1 | Enrichment | GLI3 | 0.84 |
| 326 | Corpus callosum, agenesis of | Enrichment | ARX | 0.84 |
| 327 | Osteogenesis imperfecta, type iii | Enrichment | WNT1 | 0.84 |
| 328 | Anterior segment dysgenesis | Enrichment | PAX6 | 0.84 |
| 329 | Isolated corpus callosum agenesis | Enrichment | ARX | 0.84 |
| 330 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | ARX | 0.84 |
| 331 | Male infertility with spermatogenesis disorder | Enrichment | HESX1 | 0.84 |
| 332 | Noonan syndrome and noonan-related syndrome | Enrichment | RIT1 | 0.84 |
| 333 | Creatine phosphokinase, elevated serum | Enrichment | DMD | 0.81 |
| 334 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | JUP | 0.81 |
| 335 | Isolated elevated serum creatine phosphokinase levels | Enrichment | DMD | 0.81 |
| 336 | Inherited cancer-predisposing syndrome | Enrichment | BMPR1A, NF2, SMAD4 | 0.80 |
| 337 | Congenital disorder of glycosylation, type in | Enrichment | PGM1 | 0.79 |
| 338 | Polycystic liver disease | Enrichment | CTNNB1 | 0.79 |
| 339 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 0.79 |
| 340 | Beckwith-wiedemann syndrome | Enrichment | DMD | 0.77 |
| 341 | Human immunodeficiency virus type 1 | Enrichment | CCL2 | 0.77 |
| 342 | Patent foramen ovale | Enrichment | GATA6 | 0.77 |
| 343 | Early infantile developmental and epileptic encephalopathy | Enrichment | ARX | 0.77 |
| 344 | Esophageal atresia/tracheoesophageal fistula | Enrichment | CELSR2 | 0.74 |
| 345 | Endometrial cancer | Enrichment | FGFR2 | 0.71 |
| 346 | Hepatoblastoma | Enrichment | CTNNB1 | 0.71 |
| 347 | Hepatocellular carcinoma | Enrichment | CTNNB1 | 0.69 |
| 348 | Attention deficit-hyperactivity disorder | Enrichment | MECP2 | 0.69 |
| 349 | Noonan syndrome 1 | Enrichment | RIT1 | 0.67 |
| 350 | Brittle bone disorder | Enrichment | WNT1 | 0.67 |
| 351 | Kallmann syndrome | Enrichment | HESX1 | 0.67 |
| 352 | Parkinson disease, late-onset | Enrichment | SNCA | 0.65 |
| 353 | Familial atrial fibrillation | Enrichment | GATA6 | 0.65 |
| 354 | Muscular dystrophy | Enrichment | DMD | 0.65 |
| 355 | Pancreatic cancer | Enrichment | SMAD4 | 0.64 |
| 356 | Developmental and epileptic encephalopathy 1 | Enrichment | ARX | 0.64 |
| 357 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | NARS2, SERPINB6 | 0.63 |
| 358 | Tetralogy of fallot | Enrichment | GATA6 | 0.62 |
| 359 | Hydrops fetalis, nonimmune | Enrichment | RIT1 | 0.62 |
| 360 | Rasopathy | Enrichment | RIT1 | 0.62 |
| 361 | Bladder cancer | Enrichment | CTNNB1 | 0.58 |
| 362 | Hirschsprung disease 1 | Enrichment | GLI3 | 0.58 |
| 363 | Meckel syndrome, type 1 | Enrichment | MKS1 | 0.58 |
| 364 | Differentiated thyroid carcinoma | Enrichment | TRIM33 | 0.58 |
| 365 | Stargardt disease 1 | Enrichment | ELOVL4 | 0.57 |
| 366 | Non-immune hydrops fetalis | Enrichment | RIT1 | 0.56 |
| 367 | Ovarian cancer | Enrichment | BMPR1A, CTNNB1 | 0.55 |
| 368 | Nephronophthisis | Enrichment | AHI1 | 0.53 |
| 369 | Congenital nervous system abnormality | Enrichment | CTNNB1, MECP2 | 0.52 |
| 370 | Nervous system disease | Enrichment | CTNNB1, MECP2 | 0.52 |
| 371 | Fanconi anemia, complementation group a | Enrichment | DMD | 0.51 |
| 372 | Dystonia | Enrichment | MECP2 | 0.51 |
| 373 | Eye disease | Enrichment | AHI1 | 0.51 |
| 374 | Fetal akinesia deformation sequence 1 | Enrichment | ROR2 | 0.49 |
| 375 | Systemic lupus erythematosus | Enrichment | MECP2 | 0.47 |
| 376 | Leukemia, acute myeloid | Enrichment | BCOR | 0.47 |
| 377 | Epilepsy | Enrichment | MECP2 | 0.47 |
| 378 | Myopathy | Enrichment | DMD | 0.47 |
| 379 | Distal arthrogryposis | Enrichment | ROR2 | 0.45 |
| 380 | Bardet-biedl syndrome | Enrichment | MKS1 | 0.45 |
| 381 | Hypertrophic cardiomyopathy | Enrichment | PRKAG2 | 0.44 |
| 382 | Microcephaly | Enrichment | CTNNB1, MECP2 | 0.44 |
| 383 | West syndrome | Enrichment | ARX | 0.43 |
| 384 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | SMAD4 | 0.43 |
| 385 | Sensorineural hearing loss | Enrichment | NARS2 | 0.40 |
| 386 | Thrombocytopenia | Enrichment | SMAD4 | 0.40 |
| 387 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CTNND2 | 0.39 |
| 388 | Hereditary breast ovarian cancer syndrome | Enrichment | CTNNA2 | 0.36 |
| 389 | Myeloma, multiple | Enrichment | TCF3 | 0.35 |
| 390 | Primary ciliary dyskinesia | Enrichment | TTC14 | 0.26 |
| 391 | Rare genetic deafness | Enrichment | PAX3 | 0.25 |
| 392 | Hereditary retinal dystrophy | Enrichment | AHI1, ELOVL4, FZD4 | 0.23 |
| 393 | Fundus dystrophy | Enrichment | AHI1, ELOVL4, FZD4 | 0.23 |
| 394 | Mitochondrial disease | Enrichment | NARS2 | 0.22 |
| 395 | Leber plus disease | Enrichment | AHI1 | 0.20 |
| 396 | Retinitis pigmentosa | Enrichment | AHI1, MKS1 | 0.19 |
| 397 | Autism spectrum disorder | Enrichment | MECP2 | 0.17 |